Here's the comment on the additional AG offices joining the Philadelphia office.
Questcor Reports US Attorney's Office for Southern District of New York and Los Angeles officer of SEC Participating Join Ongoing Investigation by US Attorney's Office in Philadelphia -
The big question is -what does this mean. It's already been well over a year since the Philadelphia office investigation. Near term it proably has no effect on earnings. Thought from others on the board? Mikey - Max- My honest opinion
I never did believe it would amount to anything...One possible interpretation is that they were getting nowhere in PA and decided to try to cast a wider net...This is not an uncommon occurrence in such situations.
I remember a news story that was on 60 Minutes years ago alleging drug co.'s improper selling and promotional practices. I remember Pfizer paid a stiff fines for improper selling of their drug aranesp. They paid $762 M because they sold the drug for 'off-dosing regimens'. Unless it's as serious as this case, then the long started investigation is yet to yield enough evidence for any serious prosecution.